Chromium-Induced DNA Damage and Repair

Metal Complex-DNA Interactions

Volumn , Issue , 2009, Pages 463-489

  Little, Laura G ^a   Sugden, Kent D ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

Carbon centred radicals from ascorbate; Chromium as carcinogen and current exposure limits; Chromium DNA binding; Chromium induced DNA damage and repair; Cr (VI) induced damage at deoxyribose; Cr (VI) induced DNA crosslinks; Cr induced DNA damage and repair; Sugar oxidation

Indexed keywords

EID: 80055067955     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444312089.ch17     Document Type: Chapter

References (140)

1. Nriagu, J.O.; Neiboer, E., Eds; Chromium in Natural and Human Environments, Vol. 20, John Wiley & Sons, New York, 1998, 1998-1.
2. Katz, S. A.; Salem, H.; The Biological and Environmental Chemistry of Chromium, VCH Publishers, New York, 1994, 1994-32.
3. Cohen, M.D.; Kargacin, B.; Klein, C.B.; Costa, M.; Mechanisms of chromium carcinogenicity and toxicity; Crit. Rev. Toxicol., 1993, 23, 255-281.
4. Pfeil, R.; Lungentumoren als Berufskrankung in Chromatbetrieben; Dtsch. Med. Wochensch, 1935, 61, 1197-1202.
5. Baetjer, A.M.; Pulmonary carcinoma in chromate workers I. A review of the literature and report of cases; Arch. Indust. Hyg. Occup. Med., 1950, 2, 487-504.
6. Baetjer, A.M.; Pulmonary carcinoma in chromate workers II. Incidence on basis of hospital records; Arch. Indust. Hyg. Occup. Med., 1950, 2, 505-516.
7. Hayer, R.B.; Lilienfeld, A.M.; Snell; L.M.; Mortality in chromium chemical production workers. A prospective study; Int. J. Epidemiol., 1979, 8, 365-374.
8. Bidstrup, PL.; Carcinoma of the lung in chromate workers; Br. J. Ind. Med., 1951, 8, 302-305.
9. Bidstrup, PL.; Case, R.A.M.; Carcinoma in the lung of workmen in the bichromate-producing industry in Great Britain; Br. J. Ind. Med., 1956, 13, 260-264.
10. Royle; H.; Toxicity of chromic acid in the chrome plating industry (1); Environ. Res., 1975, 10, 39-53. '
11. Royle; H.; Toxicity of chromic acid in the chrome plating industry (2); Environ. Res., 1975, 10, 141-163.
12. Frentzel-Beyme, R.; Lung cancer mortality of workers employed in chromate pigment factories. A multicentric European epidemiological study; Cancer Res. Clin. Oncol., 1983, 105, 183-188.
13. Franchini, L.; Magnani, F.; Mutti, A.; Mortality experiences among chrome plating workers; Scand. J. Environ. Health, 1983, 9, 247-252.
14. Satoh, K.; Fukuda, Y.; Torii, K.; Katsuno, N.; Epidemiological study of workers engaged in the manufacture of chromium compounds; J. Occ. Med., 1981, 23, 835-838.
15. IARC monograph on the evaluation of carcinogenic risk to humans; chromium, nickel and welding; Lyon, France, 1990.
16. US Environmental Protection Agency; EPA Locating and Estimating Air Emissions from Sources of Chromium, Office of Air Quality Planning and Standards, Research Triangle Park, NC, 1984.
17. US Environmental Protection Agency; EPA Health Assessment Document for Chromium, Office of Air Quality Planning and Standards, Research Triangle Park, NC, 1984.
18. US Environmental Protection Agency; EPA Health Effects Assessment for Hexavalent Chromium, Office of Emergency and Remedial Response, Cincinnati, OH, 1984.
19. US Environmental Protection Agency; National Priorities List Basic Site Query Results, www.oaspub.epa.gov/oerrpage/basicqry (accessed 9 Nov 2007).
20. Occupational Safety and Health Administration; Corporate-Wide Settlement Agreements, www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=CWSA&p_id=883 (accessed 9 Nov 2007).
21. Barceloux, D.G.; Chromium; Clin. Tox., 1999, 37, 173-194.
22. Salnikow, K.; Zhitkovich, A.; Costa, M.; Analysis of the binding sites of chromium to DNA and protein in vitro and in intact cells; Carcinogenesis, 1992 13, 2341-2346.
23. Arslan, P.; Beltrame, M.; Tomasi, A.; Intracellular chromium reduction; Biochim. Biophys. Acta, 1987, 931, 10-15.
24. Kortenkamp, A.; Beyersmann, D.; O'Brien, P.; Uptake of chromium (III) complexes by erythrocytes; Toxicol. Environ. Chem., 1987, 14, 23-32.
25. Connett, P.H.; Wetterhahn; K.E.; Metabolism of the carcinogen chromate by cellular constituents; Struct. Bond., 1983, 54, 93-124.
26. Quievryn, G.; Peterson, E.; Messer, J.; Zhitkovich, A.; Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells; Biochem., 2003, 42, 1062-1070.
27. Standeven, A.M.; Wetterhahn, K.E.; Ascorbate istheprinciple reductant of chromium(VI) in rat liver and kidney ultrafiltrates; Carcinogenesis, 1991, 12, 1733-1737.
28. Stearns, D.M.; Wetterhahn, K.E.; Reaction of chromium(VI) with ascorbate produces chromium(V), chromium(IV), and carbon-based radicals; Chem. Res. Toxicol., 1994, 7, 219-230.
29. Goodgame, D.M.L.; Joy, A.M.; EPR study of the Cr(V) and radical species produced in the reduction of Cr(VI) by ascorbate; Inorg. Chim Acta, 1987, 135, 115-118.
30. Stearns, D.M.; Kennedy, L.J.; Courtney, K.D.; Giangrande, P.H.; Phieffer, L.S.; Wetterhahn, K.E.; Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro; Biochem., 1995, 34, 910-919.
31. Da Cruz Fresco, P.; Shacker, F.; Kortenkamp, A.; The reductive conversion of chromium(VI) by ascorbate gives rise to apurinic/apyrimidinic sites in isolated DNA; Chem. Res. Toxicol., 1995, 8, 884-890.
32. Lay, P.A.; Levina, A.; Activation of molecular oxygen during the reactions of chromium(VI/V/IV) with biological reductants: Implications for chromium-induced genotoxicities; J.Am. Chem. Soc., 1998, 120, 6704-6714.
33. Martin, B.D.; Schoenhard, J.A.; Hwang, J.-M.; Sugden, K.D.; Ascorbate is a pro-oxidant in chromium-treated human lung cells; Mutat. Res., 2006, 610, 74-84.
34. Connett, PH.; Wetterhahn, K.E.; In vitro reaction of the carcinogen chromate with cellular thiols and carboxylic acids; J. Am. Chem. Soc., 1985, 107, 4282-4288.
35. Bose, R.N.; Moghaddas, S.; Gelerinter, E.; Long-lived chromium(IV) and chromium(V) metabolites in the chromium(VI)-glutathione reaction: NMR, ESR, HPLC, and kinetic characterization; Inorg. Chem., 1992, 31, 987-1994.
36. Borges, K.M.; Boswell, J.S.; Liebross, R.H.; 'We tterhahn, K.E.; Activation of chromium(VI) by thiols results in chromium(V) formation, chromium binding to DNA and altered DNA conformation; Carcinogenesis, 1991, 12, 551-561.
37. Kortenkamp, A.; Casadevall, M.; Faux, S.P.; Jenner, A.; Shayer, R.O.J.; Woodbridge, N.; O'Brien; P.; A role for molecular oxygen in the formation of DNA damage during the reduction of the carcinogen chromium(VI) by glutathione; Arch. Biochem. Biophys., 1996, 329, 199-207.
38. Sevilla, M.D.; Becker, D.; Swarts, S.; Herrington, J.; Sulfinyl radical formation from the reaction of cysteine and glutathione thiyl radicals with molecular oxygen; Biochem. Biophys. Res. Commun., 1987, 144, 1037-1042.
39. Tomaszewski, K.E.; Agarwal, D.K.; Melnick, R.L.; In vitro steady-state levels of hydrogen peroxide after exposure of male F344 rats and female B6C3F1 mice to hepatic peroxisome proliferators; Carcinogenesis, 1986, 7, 1871-1876.
40. eneration in perfused rat liver and the reaction of catalase compound I and hydrogen donors; Arch. Biochem. Biophys., 1973, 154, 117-131.
41. Chance, B.; Sies, H.; Boveris, A.; Hydroperoxide metabolism in mammalian organs; Physiol Rev., 1979, 69, 527-605.
42. Shi, X.; Dalal, N.S.; The role of superoxide radical in chromium(VI) generated hydroxyl radical: The Cr(VI) Haber-Weiss cycle; Arch. Biochem. Biophys., 1992, 292, 323-327.
43. Zhang, L.; Lay, P.A.; EPR spectroscopic studies on the formation of chromium(V) peroxo complexes in the reaction of chromium(VI) with hydrogen peroxide; Inorg. Chem., 1998, 37, 1729-1733.
44. Shi, X.; Dalal, N.S.; Generation of hydroxyl radical by chromate in biologically relevant systems: Role of Cr(V) complexes versus tetraperoxochromate(V); Environ. Health Perspect, 1994, 102(3), 231-236.
45. O'Brien, T.J.; Ceryak, S.; Patierno, S.R.; Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms; Mutat. Res., 2003, 533, 3-36.
46. Chen, J.; Thilly, W.G.; Mutational spectrum of chromium(VI) in human cells; Mutat. Res., 1994, 323, 21-27.
47. Sen, P.; Costa, M.; Incidence and localization of sister chromatid exchanges induced by nickel and chromium compounds; Carcinogenesis, 1986, 7, 1527-1533.
48. Sarto, F.; Cominato, V.; Bianchi, V.; Levis, A.G.; Increased incidence of chromosomal aberrations and sister chromatid exchanges in workers exposed to chromic acid (CrO3) in electroplating factories; Carcinogenesis, 1982, 3, 1011-1016.
49. Elias, Z.; Schneider, O.; Aubry, F.; Daniere, M.C.; Poirot, O.; Sister chromatid exchanges in Chinese hamster V79 cells treated with the trivalent chromium compounds chromic chloride and chromic oxide; Carcinogenesis, 1983, 4, 605-611.
50. US Environmental Protection Agency; Consumer Factsheet on: Chromium. 21 Feb. 2006. EPA Ground Water and Drinking Water, www.epa.gov/safewater/contaminants/dw_con-tamfs/chromium.html (accessed 9 Nov 2007).
51. Liebross, R.H.; Wetterhahn, K.E.; In vivo formation of chromium(V) in chick embryo red blood cells; Chem. Res. Toxicol., 1990, 3, 401-403.
52. Rossi, S.C.; Gorman, N.; Wetterhahn, K.E.; Mitochondrial reduction of the carcinogen chromate: formation of chromium(V); Chem. Res. Toxicol., 1988, 1, 101-107.
53. Tsou, T.C.; Yang, J.L.; Formation of reactive oxygen species and DNA strand breakage during interaction of chromium(III) and hydrogen peroxide in vitro; evidence for a chromium(III)-mediated Fenton-like reaction; Chem. Biol. Interact., 1996, 102, 133-153.
54. Aiyar, J.; Berkovits, H.J.; Floyd, R.A.; Wetterhahn, K.E.; Reaction of chromium(VI) with hydrogen peroxide in the presence of glutathione: reactive intermediates and resulting DNA damage; Chem. Res. Toxicol., 1990, 3, 595-603.
55. Aiyar, J.; Berkovits, H.J.; Floyd, R. A.; Wetterhahn, K.E.; Reaction of chromium(VI) with glutathione or with hydrogen peroxide: identification of reactive intermediates and their role in chromium(VI)-induced DNA damage; Environ. Health Perspect., 1991, 92, 53-62.
56. Mueller, S.; Riedel, H.D.; Stremmel, W.; Determination of catalase activity at physiological hydrogen peroxide concentrations; Anal. Biochem., 1997, 245, 55-60.
57. Bose, R.N.; Fonkeng, B.S.; Moghaddas, S.; Stroup, D.; Mechanisms of DNA damage by chromium(V)-DNA carcinogens; Nucl. Acids Res., 1998, 26, 1588-1596.
58. Steenken, S.; Jovanovic, S.; How easily oxidizable is DNA? One-electron reduction potentials of adenosine and guanosine radicals in aqueous solution; J. Am. Chem. Soc., 1997, 119, 617-618.
59. Yanagawa, H.; Ogawa, Y.; Ueno, M.; Redox ribonucleotides. Isolation and characterization of 5-hydroxyuridine, 8-hydroxyguanosine, and 8-hydroxyadenosine from Torula yeast RNA; J. Biol. Chem., 1992, 267, 13320-13326.
60. Saito, I.; Takayama, M.; Sugiyama, H.; Nakatani, K.; Photoinduced DNA cleavage via electron transfer: demonstration that guanine residues located 5' to guanine are the most electron-donating sites; J. Am. Chem. Soc., 1995, 117, 6406-6407.
61. Shibutani, S.; Takeshita, A.; Grollman, A.P; Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG; Nature, 1991, 349, 431-434.
62. Sugden, K.D.; Wetterhahn, K.E.; Reaction of chromium(V) with the EPR spin traps 5, 5-dimethylpyrroline N-oxide and phenyl-N-tertbutylnitrone resulting in direct oxidation; Inorg. Chem., 1996, 35, 651-657.
63. Groves, J.T.; Kruper, W.J.; Preparation and characterization of an oxoporphinatochromium(V) complex; J. Am. Chem. Soc., 1979, 101, 7613-7615.
64. Neyhart, G.A.; Grover, N.; Smith, S.S.; Kalsbeck, W.A.; Fairley, T.A.; Cory, M.; Thorp, H.H.; Binding and kinetic studies of oxidation of DNA by oxoruthenium(IV); J. Am. Chem. Soc, 1993, 115, 4423-4428.
65. Luo, W.; Muller, J.G.; Rachlin, E.M.; Burrows, C.J.; Characterization of spiroiminodihy-dantoin as a product of one electron oxidation of 8-oxo-7, 8 dihydroguanosine; Org. Lett., 2000, 2, 613-616.
66. Hailer, M.K.; Slade, P.G.; Martin, B.D.; Sugden, K.D.; Nei deficient Escherichia coli are sensitive to chromate and accumulate the oxidized guanine lesion spiroiminodihydan-toin; Chem. Res. Toxicol., 2005, 18, 1378-1383.
67. Steenken, S.; Jovanovic, S.V.; Bietti, M.; Bernhard, K.; The trap depth (in DNA) of 8-oxo-7, 8-dihydro-2 'deoxyguanosine as derived from electron-transfer equilibria in aqueous solution; J. Am. Chem. Soc., 2000, 122, 2373-2374.
68. Delaney, S.; Barton, J.K.; Long range DNA charge transport; J. Org. Chem., 2003, 68, 6475-6483.
69. Slade, P.G.; Priestley, N.P.; Sugden, K.D.; Spiroiminodihydantoin as an oxo-atom transfer product of 8-oxo-2'-deoxyguanosine oxidation by chromium(V); Org. Lett., 2007, 9, 4411-4414.
70. Duarte, V.; Muller, J.G.; Burrows, C.J.; Insertion of dGMP and dAMP during; n vitro DNA synthesis opposite an oxidized form of 7, 8-dihydro-8-oxoguanine; Nucleic Acids Res, 1999, 27, 496-502.
71. Henderson, P.T.; Delaney, J.C.; Muller, J.G.; Neeley, W.L.; Tannenbaum, S.R.; Burrows, C.J.; Essigmann, J.M.; The hydantoin lesions formed from oxidation of 7, 8-dihydro-8-oxoguanine are potent sources of replication errors in vivo; Biochem., 2003, 42, 9257-9262.
72. Kornyushyna, O.; Berges, A.M.; Muller, J.G.; Burrows, C.J.; In vitro nucleotide misinser-tion opposite the oxidized guanosine lesions spiroiminodihydantoin and guanidinohy-dantoin and DNA synthesis past the lesions using Escherichia coli DNA polymerase I (Klenow fragment); Biochem., 2002, 41, 15304-15314.
73. Sugden, K.D.; Campo, C.K.; Martin, B.D.; Direct oxidation of guanine and 7, 8-dihydro-8-oxoguanine in DNA by a high valent chromium complex: A possible mechanism for chromate genotoxicity; Chem. Res. Toxicol., 2001, 14, 1315-1322.
74. Sugden, K.D.; Martin, B.D.; Guanine and 7, 8-dihydro-8-oxo-guanine-specific oxidation in DNA by chromium(V); Environ. Health Perspect., 2002, 110(5), 725-728.
75. Aburantani, H.; Hippou, Y.; Ishida, T.; Takashima, R.; Matsuba, C.; Kodama, M.T.; Yasui, A.; Yamamoto, K.; Asano, M.; Fukasawa, K.; Yoshinari, T.; Inoue, H.; Ohtsuka, E.; Nishimura, S.; Cloning and characterization of mammalian 8-hydroxyguanine-specific DNA glycosylase/apurinic, apyrimidinic lyase, a functional mutM homologue; Cancer Res., 1997, 57, 2151-2156.
76. Minowa, O.; Arai, T.; Hirano, M.; Monden, Y.; Nakai, S.; Fukuda, M.; Itoh, M.; Takano, H.; Hippou, Y.; Abutantani, H.; Masumura, K.; Nohmi, T.; Nishimura, S.; Noda, T.; Mmg/ Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice; Proc. Natl. Acad. Sci. USA, 2000, 97, 4156-4161.
77. Jiang, D.; Hatahet, Z.; Melamede, R.J.; Kow, Y.W.; Wallace, S.S.; Characterization of Escherichia coli endonuclease VIII; J. Biol. Chem., 1997, 272, 32230-32239.
78. Hazra, T.K.; Muller, J.G.; Manuel, R.C.; Burrows, C.J.; Lloyd, S.R.; Mitra, S.; Repair of hydantoins, one electron oxidation product of 8-oxo-guanine, by DNA glycosylases of Escherichia coli; Nucleic Acids Res., 2001, 29, 967-1974.
79. Takao, M.; Kanno, S.; Kobayashi, K.; Zhang, Q.; Yonei, S.; van der Horst, G.; Yasui, A.; A back-up glycosylase in Nth1 knock-out mice is a functional Nei (endonuclease VIII) homologue; J. Biol. Chem., 2002, 277, 42205-42213.
80. Hazra, T.K.; Kow, Y.W.; Hatahet, Z.; Imhoff, B.; Boldogh, I.; Mokkapati, S.K.; Mitra, S.; Izumi, T.; Identification and characterization of a novel human DNA glycosylase for repair of cytosine derived lesions; J. Biol. Chem., 2002, 277, 30417-30420.
81. Dou, H.; Mitra, S.; Hazra, T.K.; Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2; J. Biol. Chem, 2003, 278, 49679-49684.
82. Hailer, M.K; Slade, P.G.; Martin, B.D.; Rosenquist, T.A.; Sugden, K.D.; Recognition of the oxidized lesions spiroiminodihydantoin and guanidinohydantoin in DNA by the mammalian base excision repair glycosylases NEIL1 and NEIL2; DNA Repair, 2005, 4, 41-50.
83. Bruner, S.D.; Norman, D.P.; Verdine, G.L.; Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA; Nature, 2000, 403, 859-866.
84. Mokkapati, S.K.; Wiederhold, L.; Hazra, T.K.; Mitra, S.; Stimulation of DNA glycosylase activity of OGG1 by NEIL1: functional collaboration between two human DNA glycosylases; Biochem., 2004, 43, 11596-11604.
85. Hazra, T.K.; Izumi, T.; Boldogh, I.; Imhoff, B.; Kow, Y.W.; Jaruga, P.; Dizdaroglu, M.; Mitra, S.; Identification and characterization of a human DNA glycosylase for repair of modified bases in oxidatively damaged DNA; Proc. Natl. Acad. Sci. USA, 2002, 99, 3523-3528.
86. Dou, H.; Theriot, C.A.; Das, A.; Hedge, M.L.; Matsumoto, Y.; Boldogh, I.; Hazra, T.K.; Bhakat, K.K.; Mitra, S.; Interaction of the human DNA glycosylase NEIL1 with proliferating cell nuclear antigen: The potential for replication-associated-repair of oxidized bases in mammalian genomes; J. Biol. Chem., 2008, 283, 3130-3140.
87. Jia, L.; Shafirovich, V.; Geacintov, N.E.; Broyde, S.; Lesion specificity in the base excision repair enzyme hNeil1: Modeling and dynamoics studies; Biochem., 2007, 46, 5305-5314.
88. Sugden, K.D.; Wetterhahn, K.E.; Direct and hydrogen peroxide-induced chromium(V) oxidation of deoxyribose in single-stranded and double-stranded calf thymus DNA; Chem. Res. Toxicol., 1997, 10, 1397-1406.
89. Pogoselski, W.K.; Tullius, T.D.; Oxidative strand scission of nucleic acids: routes initiated by hydrogen abstraction from the sugar moiety; Chem. Rev., 1998, 98, 1089-1107.
90. Breen, P.A.; Murphy, J.A.; Reactions of oxyl radicals with DNA; Free Rad. Biol. Med., 1995, 18, 1033-1077.
91. Sugden, K.D.; Formation of modified cleavage terminifromthe reaction of chromium(V) with DNA; J. Inorg. Biochem., 1999, 77, 177-183.
92. Sugden, K.D.; Wetterhahn, K.E.; EPR evidence for chromium(V) binding to phosphate and pyrophosphate: implications for chromium(V)-DNA interactions; Inorg. Chem., 1996, 35, 3727-3728.
93. Caldecott, K.W.; XRCC1 and DNA strand break repair; DNA Repair, 2003, 2, 955-969.
94. Wise, S.J.P.; Wise, S.S.; Little, J.E.; The cytotoxicity and genotoxicity of particulate and soluble hexavalent chromium in human lung cells; Mutat. Res., 2002, 517, 221-229.
95. Damia, G., D'Incalci, M.; Targeting DNA repair as a promising approach in cancer therapy; Eur. J. Cancer, 2007, 43, 1791-1801.
96. Caldecott, K.W.; DNA single-strand breaks and neurodegeneration; DNA Repair, 2004, 3, 875-882.
97. Blankert, S.A.; Coryell, V.H.; Picard, B.T.; Wolf, K.K.; Lomas, R.E.; Stearns, D.M.; Characterization of nonmutagenic Cr(III)-DNA Interactions; Chem. Res. Toxicol., 2003, 16, 847-854.
98. Gelasco, A.; Lippard, S.J.; NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand crosslink, the major adduct of the anticancer drug Cisplatin; Biochem., 1998, 37, 9230-9239.
99. 2]; Science, 1982, 218, 1075-1082.
100. Zhitkovich, A.; Song, Y.; Quievryn, G.; Voitkun, V.; Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis; Biochem., 2001, 40, 549-560.
101. Snow, E.T.; Xu, L.S.; Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication; n vitro; Biochem., 1991, 30, 11238-11245.
102. Zhitkovich, A.; Importance of chromium-DNA adducts in mutagenicity and toxicity of chromium(VI); Chem. Res. Toxicol., 2005, 18, 3-11.
103. Peterson-Roth, E.; Reynolds, M.; Quievryn, G.; Zhitkovich, A.; Mismatch repair proteins are activators of toxic responses to chromium-DNA damage; Mol. Cell. Biol., 2005, 25, 3596-3607.
104. Reynolds, M.; Zhitkovich, A.; Cellular vitamin C increases chromate toxicity via a death program requiring mismatch repair but not p53; Carcinogenesis, 2007, 28, 1613-1620.
105. Strauss-Soukup, J.K.; Vaghefi, M.M.; Hogrefe, R.I.; Maher III, L.J.; Effects of neutralization pattern and stereochemistry on DNA bending by methylphosphonate substitutions; Biochem., 1997, 36, 8692-8698.
106. Jiricny, J.; Nyström-Lahti, M.; Mismatch repair defects in cancer; Curr. Opin. Genet. Dev., 2000, 10, 157-161.
107. Modrich, P.; Lahue, R.; Mismatch repair in replication fidelity, genetic recombination, and cancer biology; Annu. Rev. Biochem., 1996, 65, 101-133
108. Kolodner, R.D.; Marsischky, G.T.; Eukaryotic DNA mismatch repair; Curr. Opin. Genet. Dev., 1999, 9, 89-96.
109. Reynolds, M.; Stoddard, L.; Bespalov, I.; Zhitkovich, A.; Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair; Nucleic Acids Res., 2007, 35, 465-476.
110. Hirose, T.; Kondo, K.; Takahashi, Y.; Ishikura, H.; Fujino, H.; Tsuyuguchi, M.; Hashimoto, M.; Yokose, T.; Mukai, K.; Kodama, T.; Moden, Y.; Frequent microsatellite instability in lung cancer from chromate-exposed workers; Mol. Carcinog., 2002, 33, 172-180.
111. Kunkel, T.; Erie, D.A.; DNA mismatch repair; Annu. Rev. Biochem., 2005, 74, 681-710.
112. Modrich, P.; Mechanisms in eukaryotic mismatch repair; J. Biol. Chem., 2006, 281, 30305-30309.
113. Salnikow, K.; Zhitkovich, A.; Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium; Chem. Res. Toxicol., 2008, 21, 28-44.
114. Strauss, J.K.; Maher III, J.L.; DNA bending in asymmetric phosphate neutralization; Science, 1994, 266, 1829-1834.
115. Crothers, D.M.; Upsetting the forces of balance in DNA; Science, 1994, 266, 1819-1820.
116. Voitkun, V.; Zhitkovich, A.; Costa, M.; Complexing of amino acids to DNA by chromate in intact cells; Environ. Health Perspect., 1994, 102(3), 251-255.
117. Zhitkovich, A.; Voitkun, V.; Costa, M.; Formation of amino acid-DNA complexes by hexavalent and trivalent chromium in vitro: importance of trivalent chromium and the phosphate group; Biochem., 1996, 35, 7575-7582.
118. Nickoloff, J.A.; Heokstra, M.F.; DNA Damage and Repair, Vol. II: DNA Repair in Higher Eukaryotes, Humana Press Inc., Totowa, NJ, 1998, 1998-350.
119. Andrews, A.D.; Barrett, S.F.; Yoder, F.W.; Robbins, J.H.; Xeroderma pigmetosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation; Proc. Natl. Acad. Sci. USA, 1978, 75, 1984-1988.
120. Burns, J.L.; Guzder, S.N.; Sung, P.; Prakash, S.; Prakash, L.; An affinity of human replication protein A for ultraviolet-damaged DNA; J. Biol. Chem., 1996, 271, 11607-11610.
121. Clugston, C.K.; McLaughlin, K.; Kenny, M.K.; Brown, R.; Binding of human singlestranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II); Cancer Res., 1992, 52, 6375-6379.
122. Matsuda, T.; Saijo, M.; Kuraoka, I.; Kobayashi, T.; Nakatsu, Y.; Nagai, A.; Enjoji, T.; Masutani, C.; Sugasawa, K.; Hanaoka, F.; Yasui, A.; Tanaka, K.; DNA repair protein XPA binds replication protein A (RPA); J. Biol. Chem., 1992, 270, 4152-4157.
123. Schaeffer, L.; Roy, R.; Humbert, S.; Moncollin, V.; Vermeulen, W.; Hoeijmakers, J.H.J.; Chambon, P.; Egly, J.M.; DNA repair helicase: a component of BTF2 (TFIIH) basic transcription factor; Science, 1993, 260, 58-63.
124. Sung, P.; Bailly, V.; Weber, C.; Thompson, L.H.; Prakash, L.; Prakash, S.; Human Xeroderma pigmentosum group D gene encodes a DNA helicase; Nature, 1993, 365, 852-855.
125. O'Donovan, A.; Scherly, D.; Clarkson, S.G.; Wood, R.G.; Isolation of active recombinant XPG protein, a human DNA repair endonuclease; J. Biol. Chem., 1994, 269, 15965-15968.
126. Matsunaga, T.; Mu, D.; Park, C.H.; Reardon, J.T.; Sancar, A.; Human DNA repair excision nuclease; J. Biol. Chem., 1995, 270, 20862-20869.
127. Huang, J.C.; Svoboda, D.L.; Reardon, J.T.; Sancar, A.; Human nucleotide excision nuclease removes thymine dimmers from DNA by incising the 22nd phosphodiester bond 5' and the 6th phosphodiester bond 3' to the photodimer; Proc. Natl. Acad. Sci. USA, 1992, 89, 3664-3668.
128. Mu, D.; Hsu, D.S.; Sancar; A.; Reaction mechanism of human DNA repair excision nuclease; J. Biol. Chem., 1996, 271, 8285-8294.
129. Park, C.H.; Bessho, T.; Matsunaga, T.; Sancar, A.; Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease; J. Biol. Chem., 1995, 270, 22657-22660.
130. Nichols, A.F.; Sancar, A.; Purification of PCNA as a nucleotide excision repair protein; Nucleic Acids Res., 1992, 20, 2441-2446.
131. Hubscher, U.; Spadari, S.; DNA replication and chemotherapy; Physiol. Rev., 1994, 74, 259-304.
132. O'Brien, T.; Mandel, H.G.; Pritchard, D.E.; Patierno, S.R.; Critical role of chromium (Cr)-DNA interactions in the formation of Cr-induced polymerase arresting lesions; Biochem., 2002, 41, 12529-12537.
133. Bridgewater, L.C.; Manning, F.C.; Patierno, S.R.; Base-specific arrest of m vitro DNA replication by carcinogenic chromium: relationship to DNA interstrand crosslinking; Carcinogenesis, 1994, 15, 2421-2427.
134. Bridgewater, L.C.; Manning, F.C.; Patierno, S.R.; Arrest of replication by mammalian DNA polymerases α and β caused by chromium-DNA lesions; Mol. Carcinog., 1998, 23, 201-206.
135. Helleday, T.; Nilsson, R.; Jenssen, D.; Arsenic(III) and heavy metal ions induce intrac-hromosomal homologous recombination in the hprt gene of V79 Chinese hamster cells; Environ. Mol. Mutagen., 2000, 35, 114-122.
136. O'Brien, T.J.; Fornsaglio, J.L.; Ceryak, S.R.; Patierno, S.R.; Effects of hexavalent chromium on the survival and cell cycle distribution of repair-deficient S. cerevisiae; DNA Repair, 2002, 1, 617-627.
137. Helleday, T.; Lo, J.; van Gent, D.C.; Engelward, B.P.; DNA double-strand break repair: from mechanistic understanding to cancer treatment; DNA Repair, 2007, 6, 923-935.
138. Strumberg, D.; Pilon, A.A.; Smith, M.; Hickey, R.; Malkas, L.; Pommier, Y.; Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoff; Mol. Cell. Biol., 2000, 20, 3977-3987.
139. Richardson, C.; Moynahan, M.E.; Jasin, M.; Double-strand break repair by interchromo-somal recombination: suppression of chromosomal translocations; Genes Dev., 2000, 12, 3831-3842.
140. Richardson, C.; Jasin, M.; Frequent chromosomal translocations induced by DNA double-strand breaks; Nature, 2000, 405, 676-700.